抗丙二醛-乙醛加合物抗体与美国退伍军人中现患和新发类风湿关节炎相关间质性肺病相关
在多中心前瞻性美国退伍军人RA队列(2739例)中,IgM抗MAA-胶原、IgA抗MAA-纤维蛋白原及IgA/IgG抗MAA-波形蛋白抗体与现患RA-ILD相关;IgA和IgM抗MAA-白蛋白抗体与新发RA-ILD风险升高相关,最高四分位组风险约增两倍。
要点
- IgA和IgM抗MAA-白蛋白抗体最高四分位组新发RA-ILD风险约增两倍。
- IgM抗MAA-胶原、IgA抗MAA-纤维蛋白原及IgA/IgG抗MAA-波形蛋白与现患RA-ILD相关。
- 抗MAA-纤维蛋白原、抗MAA-胶原和抗MAA-波形蛋白各同种型与新发RA-ILD无显著相关。
核心结论
- 针对胶原、纤维蛋白原和波形蛋白的蛋白特异性抗MAA抗体与现患RA-ILD相关。
- IgA和IgM抗MAA-白蛋白抗体与新发RA-ILD风险升高相关。
- 这些发现提示MAA修饰及 resultant 免疫反应可能参与RA-ILD发病机制。
研究设计与样本
- 在多中心前瞻性美国退伍军人RA队列中,通过病历回顾临床诊断、胸部影像和病理验证RA-ILD。
- 采用标准化酶联免疫吸附试验测定血清抗MAA-白蛋白、抗MAA-胶原、抗MAA-纤维蛋白原和抗MAA-波形蛋白抗体(IgA、IgM和IgG)。
- 使用多变量回归模型评估抗MAA抗体与现患及新发RA-ILD的关联,并校正已确定的RA-ILD危险因素。
主要发现
- 2739例RA参与者中(88%男性,平均年龄64岁),现患RA-ILD 114例,新发RA-ILD 136例(平均诊断时间6.6年)。
- 现患RA-ILD分析中,IgM抗MAA-胶原(每1 SD:aOR 1.28,95%CI 1.02-1.61)、IgA抗MAA-纤维蛋白原(aOR 1.48,95%CI 1.14-1.92)、IgA抗MAA-波形蛋白(aOR 1.78,95%CI 1.34-2.37)和IgG抗MAA-波形蛋白(aOR 1.48,95%CI 1.14-1.92)抗体与其相关。
- 新发分析中,IgA抗MAA-白蛋白(每1 SD:aHR 1.40,95%CI 1.11-1.76)和IgM抗MAA-白蛋白(aHR 1.29,95%CI 1.04-1.60)抗体浓度与ILD风险升高相关。
- IgA抗MAA-白蛋白(aHR 2.13,95%CI 1.16-3.90)或IgM抗MAA-白蛋白(aHR 1.98,95%CI 1.08-3.64)抗体浓度最高四分位组的新发RA-ILD风险约增两倍。
- 所有同种型中,抗MAA-纤维蛋白原、抗MAA-胶原和抗MAA-波形蛋白抗体与新发RA-ILD无显著相关。
关键数值与推荐
- 现患RA-ILD关联:IgM抗MAA-胶原每1 SD aOR 1.28(95%CI 1.02-1.61);IgA抗MAA-纤维蛋白原aOR 1.48(95%CI 1.14-1.92);IgA抗MAA-波形蛋白aOR 1.78(95%CI 1.34-2.37);IgG抗MAA-波形蛋白aOR 1.48(95%CI 1.14-1.92)。
- 新发RA-ILD关联:IgA抗MAA-白蛋白每1 SD aHR 1.40(95%CI 1.11-1.76);IgM抗MAA-白蛋白aHR 1.29(95%CI 1.04-1.60)。
- 最高四分位组新发RA-ILD风险:IgA抗MAA-白蛋白aHR 2.13(95%CI 1.16-3.90);IgM抗MAA-白蛋白aHR 1.98(95%CI 1.08-3.64)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study is to determine the associations of protein-specific anti-malondialdehyde-acetaldehyde (MAA) antibodies with prevalent and incident rheumatoid arthritis-interstitial lung disease (RA-ILD). METHODS: Within a multicenter, prospective cohort of US veterans with RA, RA-ILD was validated by medical record review of clinical diagnoses, chest imaging, and pathology. Serum antibodies to MAA-albumin, MAA-collagen, MAA-fibrinogen, and MAA-vimentin (IgA, IgM, and IgG) were measured by a standardized enzyme-linked immunosorbent assay. Associations of anti-MAA antibodies with prevalent and incident RA-ILD were assessed using multivariable regression models adjusting for established RA-ILD risk factors. RESULTS: Among 2,739 participants with RA (88% male, mean age of 64 years), there were 114 with prevalent and 136 with incident RA-ILD (average time to diagnosis: 6.6 years). Higher IgM anti-MAA-collagen (per 1 SD: adjusted odds ratio [aOR] 1.28, 95% confidence interval [CI] 1.02-1.61), IgA anti-MAA-fibrinogen (aOR 1.48, 95% CI 1.14-1.92), and IgA (aOR 1.78, 95% CI 1.34-2.37) and IgG (aOR 1.48, 95% CI 1.14-1.92) anti-MAA-vimentin antibodies were associated with prevalent RA-ILD. In incident analyses, higher IgA (per one SD: adjusted hazards ratio [aHR] 1.40, 95% CI 1.11-1.76) and IgM (aHR 1.29, 95% CI 1.04-1.60) anti-MAA-albumin antibody concentrations were associated with increased ILD risk. Participants with IgA (aHR 2.13, 95% CI 1.16-3.90) or IgM (aHR 1.98, 95% CI 1.08-3.64) anti-MAA-albumin antibody concentrations in the highest quartile had an approximately two-fold increased risk of incident RA-ILD. Across all isotypes, anti-MAA-fibrinogen, anti-MAA-collagen, and anti-MAA-vimentin antibodies were not significantly associated with incident RA-ILD. CONCLUSION: Protein-specific anti-MAA antibodies to collagen, fibrinogen, and vimentin were associated with prevalent RA-ILD. IgA and IgM anti-MAA-albumin antibodies were associated with a higher risk of incident RA-ILD. These findings suggest that MAA modifications and resultant immune responses may contribute to RA-ILD pathogenesis.
引用
- Aripova N, Thiele GM, Duryee MJ, et al. Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans. Arthritis Rheumatol. 2024. PMID: 38766737. doi:10.1002/art.42916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。